Federal contractors / XLCARE PHARMACEUTICALS INC

IDV vehicle

36E79726D0007

3 LINE ITEMS FOR MONTELUKAST 10MG TABLET. AWARDED FOR A BASE YEAR OF 5/10/2026 TO 5/9/2027 PLUS 4 ONE-YEAR OPTION PERIODS.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Veterans Affairs
OfficeNAC PHARMACEUTICALS (36E797)
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$0
Current contract valueNot reported
Potential contract value / ceiling$24.8M
Start dateMay 10, 2026
Current end dateNot available
Potential end dateNot available
Latest award activitySep 10, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Sep 10, 2026P00001$0DEI MOD
Jan 8, 20260$03 LINE ITEMS FOR MONTELUKAST 10MG TABLET. AWARDED FOR A BASE YEAR OF 5/10/2026 TO 5/9/2027 PLUS 4 ONE-YEAR OPTION PERIODS.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Diana MartinezContract Specialistdiana.martinez1@va.govSourceOct 21, 2025
Kenneth LayContract SpecialistKenneth.Lay@va.govSourceOct 20, 2025
Kenneth LayContract SpecialistKenneth.Lay@va.govSourceOct 17, 2025
Kenneth LayContract SpecialistKenneth.Lay@va.gov
708-786-4879		SourceSep 12, 2025

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.